Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

DuPont Merck presents new thrombin inhibitor

April 17, 1997

Novel aggregation pathway identified

April 16, 1997

Roberts' Agrylin available today in U.S.

April 14, 1997

FK-633 inhibits thrombosis and prevents restenosis in hamster model

April 14, 1997

Integrilin MAA withdrawn; companies await PURSUIT results

April 14, 1997

Genentech granted U.S. patents for factor VIII

April 11, 1997

Cohesion initiates clinical trials of CollaSeal

April 10, 1997

Xenova reports encouraging data on antithrombotic compound

April 10, 1997

T-686 inhibits PAI-1 and development of atherosclerotic lesions

April 8, 1997

Inogatran exerts selective inhibition of thrombin in vitro

April 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...